Kalvista Pharmaceuticals Valuation
| KALV Stock | USD 11.44 0.13 1.12% |
At this time, the firm appears to be undervalued. Kalvista Pharmaceuticals secures a last-minute Real Value of $13.51 per share. The latest price of the firm is $11.44. Our model forecasts the value of Kalvista Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 419.98 M, shares owned by insiders of 1.14 %, and Return On Equity of -0.79 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Kalvista Pharmaceuticals' valuation include:
Price Book 5.6627 | Enterprise Value 420 M | Enterprise Value Ebitda (3.53) | Price Sales 107.4168 | Enterprise Value Revenue 76.3323 |
Undervalued
Today
Please note that Kalvista Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Kalvista Pharmaceuticals is based on 3 months time horizon. Increasing Kalvista Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kalvista Pharmaceuticals is useful when determining the fair value of the Kalvista stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kalvista Pharmaceuticals. Since Kalvista Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kalvista Stock. However, Kalvista Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.44 | Real 13.51 | Target 20.67 | Hype 11.43 |
The real value of Kalvista Stock, also known as its intrinsic value, is the underlying worth of Kalvista Pharmaceuticals Company, which is reflected in its stock price. It is based on Kalvista Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Kalvista Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kalvista Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kalvista Pharmaceuticals helps investors to forecast how Kalvista stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kalvista Pharmaceuticals more accurately as focusing exclusively on Kalvista Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kalvista Pharmaceuticals' intrinsic value based on its ongoing forecasts of Kalvista Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kalvista Pharmaceuticals' closest peers. When choosing an evaluation method for Kalvista Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Kalvista Pharmaceuticals Investments |
|
Kalvista Valuation Trend
Knowing Kalvista Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Kalvista Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Kalvista Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Kalvista Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Kalvista Market Cap
Kalvista Pharmaceuticals is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 27.87 Billion. Kalvista Pharmaceuticals claims roughly 488.12 Million in market capitalization contributing just under 2% to equities under Health Care industry.Kalvista Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Kalvista Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Kalvista Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kalvista Pharmaceuticals competition to find correlations between indicators driving Kalvista Pharmaceuticals's intrinsic value. More Info.Kalvista Pharmaceuticals is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Price To Book Ratio is likely to climb to -0.44 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Kalvista Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kalvista Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kalvista Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kalvista Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kalvista Pharmaceuticals and how it compares across the competition.
About Kalvista Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Kalvista Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Kalvista Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kalvista Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Kalvista Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Kalvista Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kalvista Pharmaceuticals. We calculate exposure to Kalvista Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kalvista Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 29 K | 27.6 K | |
| Pretax Profit Margin | (3.60) | (3.79) | |
| Operating Profit Margin | (4.04) | (4.24) | |
| Net Loss | (3.60) | (3.79) | |
| Gross Profit Margin | 1.09 | 1.08 |
8 Steps to conduct Kalvista Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kalvista Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kalvista Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kalvista Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kalvista Pharmaceuticals' revenue streams: Identify Kalvista Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kalvista Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kalvista Pharmaceuticals' growth potential: Evaluate Kalvista Pharmaceuticals' management, business model, and growth potential.
- Determine Kalvista Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kalvista Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Kalvista Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Kalvista Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 27.9 M |
Kalvista Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Kalvista Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kalvista we look at many different elements of the entity such as Kalvista's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Kalvista Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kalvista Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kalvista Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kalvista Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kalvista Pharmaceuticals' worth.When determining whether Kalvista Pharmaceuticals is a strong investment it is important to analyze Kalvista Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kalvista Pharmaceuticals' future performance. For an informed investment choice regarding Kalvista Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Kalvista Stock analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Kalvista Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kalvista Pharmaceuticals. If investors know Kalvista will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kalvista Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.12) | Revenue Per Share 0.214 | Quarterly Revenue Growth 0.307 | Return On Assets (0.42) | Return On Equity (0.79) |
The market value of Kalvista Pharmaceuticals is measured differently than its book value, which is the value of Kalvista that is recorded on the company's balance sheet. Investors also form their own opinion of Kalvista Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kalvista Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kalvista Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kalvista Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kalvista Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalvista Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalvista Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.